Voluntis, AstraZeneca to test companion app in ovarian cancer studies
The app will help clinicians and patients manage side effects of hypertension and diarrhoea, which can be associated with therapy with cediranib and olaparib.
Roche, Voluntis team-up over a mobile therapy for breast cancer
Said therapy will be evaluated in a clinical trial in France, and will involve an app and telemedicine services to monitor patients between doctor visits.